After switching to every-other-week injections, people lost an additional 2 to 4 pounds (lb) on average, and body fat loss improved slightly but stayed about the same
Patients with a personal history of an endocrine-system cancer should avoid these drugs altogether
About 69% of semaglutide users lose at least 10% of body weight, compared to approximately 33% of Saxenda users
Pooled data from seven randomized controlled trials involving 680 adult participants demonstrated meaningful weight-loss outcomes, with non-diabetic individuals achieving reductions of up to 8.44% and diabetic participants achieving approximately 3.55% weight loss over a 24-week periods
Chronic low-grade inflammation, sometimes called inflammaging, is linked to heart disease, cognitive decline, metabolic issues, and many age-related conditions